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Transgenic mice expressing the IL-5 gene (IL-5-Tg) ex-Hiroko Sugaya,§ Kazushige Maki,³
Mineo Takagi,² Hiroko Kanazawa,* hibit elevated serum levels of IgM, IgA, and IgE, and
increase in numbers of B-1 cells, autoantibody produc-Shinji Sunaga,³ Tatsuo Kinashi,*
Kentarou Yoshimura,§ Jun-ichi Miyazaki,³ tion, and persistent eosinophilia (Dent et al., 1990; Tomi-
naga et al., 1991). These studies show that IL-5 is criti-Satoshi Takaki,* and Kiyoshi Takatsu*
*Department of Immunology cally involved in the development and activation of B
cells and eosinophils in vivo.²Department of Stem cell Regulation
Institute of Medical Science The IL-5 receptor (IL-5R)consists of two distinct mem-
brane proteins, a and bc, each of which is a member³Department of Disease-Related
Gene Regulation Research (Sandoz) of the cytokine receptor superfamily (Mita et al., 1989;
Murata et al., 1992; Takaki et al., 1990, 1991, 1993; Ta-Faculty of Medicine
University of Tokyo, 4-6-1 katsu et al., 1994; Tavernier et al., 1991). The binding of
IL-5 occurs through the IL-5Ra chain, and the bc chainShirokanedai, Minato-ku
Tokyo 108 forms a high affinity IL-5R in combination with the IL-
5Ra chain. The bc chain is shared among receptors forJapan
§Department of Parasitology IL-3, granulocyte±macrophage colony-stimulating fac-
tor (GM-CSF), and IL-5 (Gorman et al., 1990; Hara andAkita University School of Medicine
Akita Miyajima, 1992; Kitamura et al., 1991; Park et al., 1992;
Takaki et al., 1991, 1993; Tavernier et al., 1991) andJapan
is required for signal transduction. Although molecular
mechanisms for IL-5 signal transduction are not fully
characterized, tyrosine phosphorylation of cellular pro-Summary
teins including the bc chain, Vav, Shc, PI-3 kinase, and
JAK2 is essential for transduction of IL-5 signals (SatohWe generated interleukin-5 receptor a chain (IL-5Ra)±
et al., 1994; Takaki et al., 1994), and cytoplasmic tailsdeficient (IL-5Ra2/2) mice by gene targeting. The IL-
of the a and bc chains are crucial for IL-5R-mediated5Ra2/2 mice showed decreased numbers of B-1 cells
signaling (Takaki et al., 1993, 1994; Miyajima et al., 1993).concomitant with low serum concentrations of IgM
Murine studies support the paradigm that a helminth-and IgG3. They showed no IL-5-induced enhancement
induced CD41 Th2 immune response results in IL-5-of B cell responses to T-independent antigens. The
induced eosinophilia and IL-4-induced switch to IgEnumber of ab T cell receptor±positive thymocytes
production. Administration of a neutralizing antibody totended to decrease in 3-week-old IL-5Ra2/2 mice, re-
IL-5 inhibits the eosinophil response to Schistosomaturning to normal by 6 weeks of age. The IL-5Ra2/2
mansoni (Coffman et al., 1989). This study gives directmice produced basal levels of eosinophils, while their
evidence that IL-5 is required for the blood and tissuebone marrow cells failed to form eosinophilic colonies
increase ineosinophils induced by helminthic infections.in response to IL-5. Impaired eosinophilopoiesis in IL-
A similar depletion of eosinophils by anti-IL-5 mono-5Ra2/2 mice enhanced the survival of Angiostrongylus
clonal antibody (MAb) was demonstrated in mice in-cantonensis. These results indicate that IL-5-induced
fected with many other parasites (Herndon and Kayes,eosinophils serve as potent effector cells in the killing
1992; Korenaga et al., 1994; Yoshimura et al., 1994).of Angiostrongylus cantonensis in mice.
Ablation of eosinophilia with anti-IL-5 MAb increases
the survival of Angiostrongylus cantonensis (A. canto-
nensis) in mice (Sasaki et al., 1993), which is consistentIntroduction
with in vitro studies demonstrating enhanced destruc-
tion of parasites by IL-5-activated eosinophils.However,Interleukin-5 (IL-5), a homodimeric glycoprotein re-
the failure of anti-IL-5 or anti-IL-4 antibodies to affectleased from T cells and mast cells (Takahashi et al.,
immunity against Schistosoma mansoni, despite abla-1990; Takatsu, 1992, 1994), was originally described as
tion of eosinophilia and IgE responses, respectively, ar-a B cell differentiation factor and then recognized as a B
gues against an essential role for IL-5 in parasite immu-cell growth factor and immunoglobulin A (IgA) enhancing
nity (Sher et al., 1990). Thus, the necessity of IL-5 andfactor (Kinashi et al., 1986; Matsumoto et al., 1989; So-
eosinophils to provide immunity against parasites re-noda et al., 1989; Yokota et al., 1987). IL-5 acts on pro-
mains controversial.genitors of B-1 cells (also known as CD5 B cells) (Kantor,
The IL-5Ra chain is present in B cells and eosinophils1991) to induce proliferation, and on mature B-1 cells
(Hitoshi et al., 1991; Murata et al., 1992; Tavernier et al.,and conventional B (B-2) cells to induce differentiation
1991; Wetzel, 1989). In particular, all B-1 cells in theinto immunoglobulin-producing cells (Hitoshi et al.,
peritoneal cavity express the IL-5Ra chain, while a small1990, 1993; Katoh et al., 1993; Mandler et al., 1993;
proportion of splenic B cells express the IL-5Ra chainTakatsu, 1992; Takatsu et al., 1995; Tominaga et al.,
(Hitoshi et al., 1990). B-1 cells can be distinguished from1989; Wetzel, 1989). IL-5 also controls the production
and functions of other hematopoietic cells, such as eo- B-2 cells by their expression of CD5 (Kantor, 1991), tis-
sue localization, self-replenishing activity, and IgM VHsinophils and basophils (Hitoshi et al., 1991; Lopez et
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usage (Herzenberg et al., 1986; Hardy and Hayakawa,
1994; Kocks and Rajewsky, 1989). B-1 cells may be a
major source of IgM and IgG3 class natural antibodies
against bacterial polysaccharides (Hardy and Haya-
kawa, 1994; Kocks and Rajewsky, 1989). B-1 cells are
not detected in murine X-linked immunodeficient (Xid)
mice, inwhich serum IgMand IgG3are low (Scher, 1982).
Xid mice are unable to respond to thymus-independent
type 2 (TI-2) antigens, and their B cells do not proliferate
when triggered by the surface IgM receptor and CD38
ligation (Mond, 1982; Kikuchi et al., 1995). These mice
exhibit B cell hyporeactivity to lipopolysaccharide (LPS)
and IL-5 stimulation (Hitoshi et al., 1993; Koike et al.,
1995). A recently identified X-linked gene that encodes
a nonreceptor-type tyrosine kinase, denoted Bruton's
tyrosine kinase, Btk, is mutated in mice with Xid (Raw-
lings et al., 1993; Thomas et al., 1993). Recently, critical
roles of Btk in multiple pathways of B-1 cell development
and function have been clearly demonstrated by gener-
ating Btk-deficient mice (Kerner et al., 1995; Khan et al.,
1995). We reported that IL-5 stimulation of CD51 early
B cell lines enhances Btk activity (Satoh et al., 1994;
Kikuchi et al., 1995). However, it is still unclear what
roles IL-5 and its receptor play in the development of
B-1 cells.
To reveal the essential functions of IL-5 in vivo, we
generated IL-5Ra2/2 mice by gene targeting in embry-
onic stem cells. We will describe that the IL-5Ra2/2 mice
show a decrease in B-1 cells, low serum concentrations
of IgM and IgG3, an impaired responsiveness to T-inde-
pendent antigen, and no eosinophilopoiesis in response
to IL-5. Furthermore, the IL-5Ra2/2 mice exhibit en-
hanced survival of A. cantonensis intracranial worms,
while intracranial worms are expelled in IL-5-Tg mice
that have massive eosinophilia.
Results
Figure 1. Production of IL-5Ra-Deficient Mice
(A) Strategy for the disruption of the IL-5Ra gene. (a) Genomic struc-Generation of IL-5Ra Chain±Deficient Mice
ture of the IL-5Ra wild-type locus. Exons are represented by closedThe vector used for the disruption of the IL-5Ra gene
bars. The lengths of diagnostic restriction fragments and locationcontained a genomic fragment spanning exons 3 and 7
of probes used for Southern blot analysis are shown. H, HindIII; P,
(Figure 1A). A translational stop codon with a HindIII site PstI; and S, SacI. (b) Targeting vector, which includes exons 3±7 of
was generated into exon 5 and a neomycin resistance the IL-5Ra gene. The linearized vector was introduced by electro-
gene cassette was inserted into exon 6, which inacti- poration into ES cells. (c) Predicted structure of the targeted IL-5Ra
locus.vates four cysteine residues that were conservedamong
(B) Southern blot analysis of drug-resistant ES clones and the prog-the cytokine receptor superfamily. An MC1±tk cassette
eny of germline chimeras. (a) SacI- or HindIII-digested genomic DNAwas ligated to the 59 end of the homologous region.
of transfectants were hybridized with probe A. PstI-digested DNA
After transfection of the linearized vector into embryonic were hybridized to probe B. (b) Probe B was hybridized to PstI-
stem (ES) cells, a total of 803 colonies resistant to both digested tail DNA from offspring of wild-type and heterozygous
G418 and FIAU were screened by Southern blot analysis and homozygous mutant animals obtained from germline chimeras
generated with the IL-5Ra-targeted ES cell clone.using a 59 flanking probe (probe A) for the IL-5Ra-tar-
(C) Expression of IL-5Ra on B cells from the peritoneal cavity. Rest-geted mutation on one allele through a homologous
ing peritoneal cells from IL-5Ra1/1, IL-5Ra1/2, and IL-5Ra2/2 6-week-recombination event. Three independent ES clones pro-
old mice were stained with biotinylated-H7 anti-IL-5Ra MAb, fol-
duced a 10.7 kb fragment derived from the targeted IL- lowed by avidin±PE and FITC±anti-B220 MAb. Cells stained were
5Ra locus in addition to the 13 kb wild-type fragment, analyzed using a FACScan instrument.
after SacI digestion (Figure 1B, a). These results were
verified by hybridization with a 39 flanking probe (probe
B) after digestion with PstI, resulting in a 13 kb mutant for the mutated allele and 8.2 kb for wild-type, which
was due to the artificially introduced HindIII site withband in addition to a 17 kb wild-type band. A HindIII
digest hybridized with probe A yielded a 6.0 kb fragment the stop codon in exon 5.
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Figure 2. Expression of Ly-1 and Mac-1 on B Cells in Pperitoneal Cavity
Resting peritoneal cells from IL-5Ra1/1 and IL-5Ra2/2 6- to 8-week-old mice were stained with biotinylated-anti-Ly-1 MAb, followed by
avidin±PE and FITC±anti-B220 MAb (A), and biotinylated anti-Mac-1 MAb, followed by avidin±PE and FITC-anti-IgM MAb (B). Expression of
CD8 and CD4 (C) and TCRab (D) in 3-week-old thymocytes. Thymocytes from IL-5Ra1/1 and IL-5Ra2/2 3-week-old mice were stained with
biotinylated-anti-CD4 MAb followed by avidin±PE and FITC±anti-CD8 MAb (C) and biotinylated anti-HSA MAb followed avidin±PE and FITC±anti-
TCRab MAb (D).
ES clones carrying the IL-5Ra-targeted mutation were those found in age-matched wild-type littermates (data
not shown). The expression of IgM, B220, HSA, BP-1,injected into blastocysts and the resulting male chime-
ras were mated with C57BL/6 females to test for germ- CD23, IL-7R, CD43, and CD38 on conventional B cells
line transmission of the mutation. By interbreeding of was also examined and found to be unaltered between
heterozygous offspring, we obtained three lineages of wild-type and the IL-5Ra2/2 mice. Total numbers of nu-
homozygous mutant animals that were onthe (129/Ola 3 cleated cells derived from the peritoneal cavity of the
C57BL/6)F2 hybrid background. Using PstI digests with IL-5Ra2/2 6- to 8-week-old mice was significantly lower
probe B, we verified that the homozygous mice showed than those in wild-type littermates (IL-5Ra2/2 mice, 1.5 3
only the 13 kb fragment of the mutant allele (Figure 1B, 106 versus IL-5Ra1/1 mice, 3.4 3 106). Analysis of B cells
b). The IL-5Ra2/2 mutation was inherited at the expected in the peritoneal cavity by flow cytometry revealed that
frequency. The IL-5Ra2/2 mice thrived and reproduced proportions of B220dull, CD51 B cells in the IL-5Ra2/2
as well as their wild-type littermates and did not exhibit mice were significantly lower (20%) and were less than
any obvious abnormalities during the first 4 months half of those in wild-type littermates (51%) (Figure 2A).
of life. This was further confirmed by the decreased proportion
To verify the lack of IL-5Ra expression on the cell of Mac-11 and IgMbright B cells in the IL-5Ra2/2 mice
surface in the IL-5Ra2/2 mice, resting peritoneal cells (Figure 2B). These results suggest that IL-5 contributes,
were stained with MAbs to both IL-5Ra and B220, and at least in part, to early development of B-1 cells.
analyzed by flow cytometry. In wild-type (IL-5Ra1/1) The number of splenic T cells and expression levels
mice, more than 59% of B2201 cells coexpressed IL- of CD4 and CD8 were normal in 8-week-old IL-5Ra2/2
5Ra, while less than 0.6% of cells in IL-5Ra2/2 mice mice. Interestingly, the number of thymocytes in
coexpressed IL-5Ra (Figure 1C). Heterozygous mice (IL- 3-week-old IL-5Ra2/2 mice (average 3.3 3 107 cells/
5Ra1/2) showed an intermediateexpression (about28%) mouse) was reduced to 20%±30% of that of wild-type
of the IL-5Ra. These results verified the disruption of littermates (average 1.4 3 108 cells/mouse) returning to
the expression of IL-5Ra in the IL-5Ra2/2 mice. normal by 6 weeks of age. FACS analysis revealed that
CD41CD82 thymocytes were reduced in IL-5Ra2/2 mice
(Figure 2C), and thymocytes expressing T cell receptorDecreased B-1 Cells and Thymocytes
in the IL-5Ra Chain±Deficient Mice (TCR)ab in wild-type and IL-5Ra2/2 mice were approxi-
mately 14% and 5.2%, respectively (Figure 2D). In partic-Total numbers of nucleated spleen and lymph node cells
were unaltered in the IL-5Ra2/2 mice as compared with ular, a decrease of HSA1TCRb1 thymocytes was obvious
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(wild-type mice, 9.9% versus IL-5Ra2/2 mice, 1.2%).
These results were not observed in thymocytes of IL-
5Ra2/2 mice at 6 weeks of age (data not shown). These
results suggest the involvement of IL-5 and the IL-5R
system in thymocyte development in early life.
Defects in Antibody Production in IL-5Ra
Chain±Deficient Mice
Intraperitoneal injections of IL-5 into mice can elevate
serum concentrations of IgM and IgG3 (Hitoshi et al.,
1993). The decreased number of B-1 cells in the IL-
5Ra2/2 mice prompted us to measure serum im-
munoglobulins by enzyme-linked immunosorbent assay
(ELISA). Serum levels of IgM and IgG3 in the IL-5Ra2/2
mice were about half and one-third, respectively, of
those of age-matched 6- to 8-week-old wild-type lit-
termates, while IgG1 and IgA levels were within the nor-
mal range (Figure 3A). While passive administration of
IL-5 into wild-type mice enhanced serum IgM levels
about 4-fold, the same treatment of the IL-5Ra2/2 mice
did not induce significant enhancement (data not
shown).
It has been shown that in vitro anti-TNP IgM antibody
response to TNP±Ficoll, a TI-2 antigen, can be enhanced
by IL-5 and that this response is impaired in Xid mice
(Hayashi et al., 1986). To evaluate the B cell response
of the IL-5Ra2/2 mice to TNP±Ficoll, the anti-TNP IgM±
plaque-forming cell (PFC) response was quantitated
after culture of spleen cells from either IL-5Ra1/1, IL-
5Ra1/2, or IL-5Ra2/2 mice with TNP±Ficoll in the ab-
sence or presence of IL-5. When spleen cells from the
IL-5Ra1/1 mice were stimulated with an appropriate
concentration of TNP±Ficoll (10 ng/ml), a significant anti-
TNP IgM±PFC response was observed in the absence
of IL-5 and this response was markedly enhanced when
IL-5 was added (Figure 3B). This IL-5-induced enhance-
ment of the anti-TNP±Ficoll IgM±PFC response was
completely abolished by the addition of anti-IL-5 (data
not shown). In contrast, spleen cells from the IL-5Ra2/2
mice cultured with TNP±Ficoll and IL-5 did not mount
an anti-TNP IgM±PFC response (Figure 3B).
CD38 ligation by anti-CD38 MAb, CS/2, can induce
proliferation of resting conventional splenic B cells and
synergize with IL-5 for enhanced proliferation and IgM
secretion (Kikuchi et al., 1995). When we stimulated B
cells from the IL-5Ra2/2 mice with CS/2 alone, they
showed proliferation to an extent similar to B cells from
wild-type mice. However, stimulation of B cells from
the IL-5Ra2/2 mice with IL-5 plus CS/2 did not show
enhanced proliferation,while Bcells from wild-type mice
did (Figure 3C). These results clearly indicate a role for
IL-5 and IL-5Ra in costimulation with CD38.
Figure 3. Humoral Immune Response to T-Independent Antigen The proliferative responses of B cells from the IL-
5Ra2/2 mice to LPS and anti-IgM plus IL-4 were similar(A) Serum levels of IgM, IgG3, IgG1, and IgA. Serum immunoglobulin
levels were determined by isotype-specific ELISA. Each spot repre-
sents an individual mouse (6±8 weeks old). Open circle denotes
wild-type and closed circle denotes the IL-5Ra2/2mice.
(B) In vitro anti-TNP IgM±PFC response in IL-5Ra2/2 6-week-old (C) Resting splenic B cells (1 3 105/well) from 8-week-old wild-type
mice. Spleen cells (1 3 106/200 ml/well) were cultured in triplicate (open circle, open square), or IL-5Ra2/2 (closed circle, closed square)
with or without 10 ng/ml of TNP±Ficoll for 4 days and then anti-TNP mice were cultured with various concentrations of CS/2, anti-CD38
IgM±PFC assays were carried out. IL-5 (100 U/ml) was added at MAb (5 mg/ml) (open square, closed square) alone or together with
beginning of the culture. Data are given as means of anti-TNP IgM± IL-5 (50 U/ml) (open circle, closed circle) for 3 days. Cells were
PFC/culture andtheir standard deviation. Open bar, medium; striped pulsed with (3H)thymidine (0.2 mCi/well) for the last 6±8 hr of the
bar, IL-5; stippled bar, TNP±Ficoll; closed bar, IL-5 1 TNP±Ficoll. culture. Results represent means and their standard deviation.
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Figure 4. B Cell Proliferative Responses
(A) T cell±depleted splenic B cells (1 3 105/
200 ml/well) from 12-week-old wild-type
(open circle) or IL-5Ra2/2 (closed circle) mice
were cultured with various concentrations of
LPS for 3 days.
(B) Splenic B cells (5 3 104/well) from wild-
type (open circle, open square) and IL-5Ra2/2
(closed circle, closed square) mice were cul-
tured with various concentrations of IL-4
(open square, closed square) alone or to-
gether with anti-IgM (2 mg/ml) (open circle,
closed circle) for 60 hr.
(C) Spleen cells (1 3 105/200 ml/well) were
cultured with medium alone (open bar) or
ConA (2 mg/ml) (closed bar) for 3 days. Cells
were pulsed with [3H]thymidine (0.2 mCi/well)
for the last 12 hr of the culture. Results repre-
sent the mean and standard deviation.
to those observed using B cells from wild-type mice while the same treatment of the IL-5Ra2/2 mice did not
induce any eosinophilia. (Table 1).(Figures 4A and 4B). T cell responses to ConA were
also normal in IL-5Ra-deficient mice (Figure 4C). These To confirm further a role of IL-5-induced eosinophilo-
poiesis in vitro, methylcellulose colony-forming unitresults clearly indicate that IL-5Ra is not involved in the
B or T cell responses to these stimuli. assays were carried out. During the culture period, dif-
ferential counts of each colony were performed. Results
clearly revealed that no eosinophil colony formation wasImpaired Eosinophilopoiesis in the IL-5Ra
Chain±Deficient Mice induced by IL-5 in the culture of bone marrow cells from
the IL-5Ra2/2 mice under conditions in which significantIL-5 has been shown to act on eosinophil precursors,
resulting in induction of proliferation and differentiation numbers of eosinophil colonies were observed from
wild-type mice (Figure 5A). Many colonies of various cellinto mature eosinophils (Dent et al., 1990; Lopez et al.,
1988; Sanderson, 1992; Tominaga et al., 1991; Yama- types were induced by either IL-3 or GM-CSF in the
culture of bone marrow cells from the IL-5Ra2/2 mice,guchi et al., 1988). First, we analyzed the peripheral
blood differential count. We did not observe significant and these were similar to colonies observed in bone
marrow culture of wild-type mice (Figure 5B).differences of peripheral blood differential counts be-
tween the wild-type and the IL-5Ra2/2 mice, except for
the percentage of eosinophils (Table 1). The propor- Protective Role of IL-5-Induced Eosinophils
in the Survival of A. cantonensistion of eosinophils in the IL-5Ra2/2 mice at both 6 and
13 weeks was slightly lower than those of the wild- Intracranial Worms
Mice infected with A. cantonensis develop marked pe-type mice.
To ensure the effect of a disruption of the IL-5Ra gene ripheral eosinophilia, and increases in cerebrospinal
fluid (CSF) and medullary eosinophils (Yoshimura et al.,on eosinophil production, we injected IL-5 intraperitone-
ally and subsequently counted numbers of eosinophils 1988). In contrast, no increase in CSF eosinophils can
be noted in A. cantonensis infected nude mice and micein the peripheral blood. Passive administration of IL-5
in wild-type mice induced an increase in the proportion treated with anti-IL-5 MAb, where pulmonary migration
of the parasite frequently occurs (Sasaki et al., 1993;of eosinophils in the peripheral blood to more than 19%,
Table 1. Peripheral Blood Cell Populations in IL-5Ra2/2 Mice
Mice IL-5 Eosinophil Neutrophil Monocyte Lymphocyte
6 weeks
1/1 2 0.9 (0.3) 19.5 (12.2) 10.0 (1.4) 69.4 (13.3)
1 19.3 (1.9) 12.2 (2.4) 17.2 (1.0) 51.2 (4.7)
1/2 2 0.4 (0.3) 14.4 (5.9) 12.3 (3.4) 73.1 (2.2)
1 18.7 (1.9) 13.3 (4.7) 13.4 (1.8) 52.8 (4.7)
2/2 2 0.3 (0.3) 34.3 (9.5) 8.5 (0.8) 57.2 (9.4)
1 0.1 (0.1) 13.0 (1.7) 9.0 (1.6) 77.9 (0.0)
13 weeks
1/1 2 2.3 (0.5) 8.4 (1.1) 7.9 (0.6) 81.5 (1.4)
1/2 2 2.5 (0.5) 10.4 (2.6) 5.9 (0.7) 81.5 (3.5)
2/2 2 1.2 (0.6) 9.9 (2.1) 5.4 (1.1) 83.5 (3.4)
Peripheral blood smears were stained with May±Gruenwald and Gimsa solution and cell types examined by 100±500 cell counts using a
microscope.
Results are expressed as the mean percentage of 3±4 mice and their standard errors (parenthesis) at 6 weeks and 13 weeks of age.
IL-5 (20,000 U/head) was injected daily for 4 days and differential counts were performed 1 day after the final injection.
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Figure 5. Colony Formation
(A) Bone marrow cells from 8-week-old wild-
type (open circle), or IL-5Ra2/2 (closed circle)
mice were incubated in semisolid culture
conditions for 18 days, together with various
concentrations of IL-5.
(B) Bone marrow cells from wild-type (open
bar), or IL-5Ra2/2 (closed bar) mice were in-
cubated in semisolid culture conditions for
18 days, together with GM-CSF (10 ng/ml)
or IL-3 (10 ng/ml). Results are the mean and
standard deviation of triplicate cultures.
Sugaya and Yoshimura, 1988). These results imply that harvested at day 20 from the IL-5Ra2/2 mice weresignifi-
cantly larger than those from wild-type mice (Figure 7C).the increase in CSF eosinophils induced by IL-5 is possi-
bly involved in the killing of intracranial worms. We fur-
ther extended this line of experiments using IL-5-Tg and Discussion
the IL-5Ra2/2 mice. To evaluate the protective effect of
eosinophils on A. cantonensis infections, we infected The Phenotype of the IL-5Ra-Deficient Mice
There is a body of evidence that IL-5 plays an importantIL-5-Tg mice with A. cantonensis and monitored eosino-
philia and worm recovery. At first, we compared eosino- role in the proliferation and differentiation of B-1 cells.
Long-term culture of bone marrow cells on a stromalphil infiltration in the CSF from IL-5-Tg mice with that
from wild-type mice. As shown in Figure 6A, the numbers cell layer together with IL-5 is able to propagate pro-B
and pre-B cells expressing the CD5antigen (B-1 progen-of eosinophils in the CSF from IL-5-Tg mice were about
5-fold as many as those from wild-type mice. Further- itor) selectively (Katoh et al., 1990; Tominaga et al.,
1989). The IL-5-Tg mice show propagated B-1 cells inmore, the number of intracranial worms recovered from
the IL-5-Tg mice was significantly reduced (Figure 6B). the spleen that can secrete IgM in response to IL-5
(Tominaga et al., 1991; Katoh et al., 1993). To evaluateMoreover, the body length of female worms recovered
from IL-5-Tg mice was significantly shorter than that of the role of IL-5 in the immune system and eosinophilo-
poiesis, we generated IL-5Ra2/2 mice. The mutation inthose recovered from wild-type mice (Figure 6C).
In contrast, the IL-5Ra2/2 mice infected with A. canto- the IL-5Ra gene was not lethal and the IL-5Ra2/2 mice
showed no obvious signs of disease under specific-nensis did not show an increase in CSF eosinophils
(Figure 7A), whereas peripheral eosinophil counts were pathogen free conditions. The IL-5Ra2/2 mice showed
a decrease of B-1 cells and thymocytes, low serum con-found to be normal and no significant difference in total
nucleated cell counts were observed between the wild- centrations of IgM and IgG3, an impaired respon-
siveness to T-independent antigens, and no eosinophil-type and the IL-5Ra2/2 mice. These results indicate de-
pressed local numbers of eosinophils in the IL-5Ra2/2 opoiesis in response to IL-5. Furthermore, the IL-5Ra2/2
mice showed enhanced survival of A. cantonensis intra-mice. The intracranial worm recovery at day 20 was
extremely high in the IL-5Ra2/2 mice as compared with cranial worms, while intracranial worms were expelled
in IL-5-Tg mice that had massive eosinophilia.that of wild-type mice (Figure 7B). Intracranial worms
Figure 6. Protective Response of IL-5-Tg
Mice to A. cantonensis Infection
(A) Eosinophil counts in the CSF of IL-5-Tg
and control mice 20 days after the infection
with A. cantonensis. Data represent mean
numbers and their standard errors. We used
10 mice for the control group and 8 mice for
the IL-5-Tg group.
(B) Worm recovery from the brain of normal
and IL-5-Tg mice 20 days after the infection.
Data represent mean numbers of worms and
their standard errors.
(C) The body length of female worms recov-
ered from the brain of normal and IL-5-Tg
mice. Data represent the mean length of 8
worms and their standard errors 20 days after
the infection. Asterisks indicate a significant
difference (*P < 0.05, **P < 0.01) between nor-
mal and IL-5-Tg mice examined by Student's
t test.
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Figure 7. Impaired Response of IL-5Ra2/2
Mice to A. cantonensis Infection.
(A) Eosinophil counts in the cerebrospinal
fluid of 9- to 11-week-old wild-type (1/1) and
IL-5Ra-deficient (2/2) mice infected with A.
cantonensis. Data represent mean numbers
of cerebrospinal eosinophils and their stan-
dard errors. We used 7 mice for each group.
(B) Worm recovery from brains of wild-type
(1/1) and IL-5a2/2 (2/2) mice infected with A.
cantonensis. Data represent mean numbers
of worm and their standard errors.
(C) Body length of female worms recovered
from brains of wild-type (1/1) and IL-5a2/2 (2/2)
mice. Data represent the mean length of male and female worms and their standard errors. Asterisks and dagger (*P < 0.02, ²P < 0.003, **P
< 0.01, ³P < 0.0001) indicate a significant difference between wild-type and IL-5Ra2/2 mice examined by Student's t test.
Reduced levels of serum immunoglobulins have been B-1 cell development and how IL-5 affects B-1 cell de-
reported in mice deficient in the CD40, CD40 ligand, velopment. We reported that Btk activation can be in-
and CD28 molecules that are involved in interactions duced in B cells from wild-type mice, but not from Xid
between B and T cells (Kawabe et al., 1994; Renshaw mice by IL-5 stimulation, CD38 ligation, and cross-link-
et al., 1994; Shahinian et al., 1993). In contrast with these ing of IgM on the B cell surface (Kikuchi et al., 1995).
mice, the IL-5Ra2/2 mice have lower serum IgM and IgG3 Furthermore, CD38 ligation of wild-type B cells in combi-
and unaltered IgG1 and IgA. Several in vitro studies have nation with IL-5 can enhance the IL-5Ra expression syn-
shown that IL-5 enhances IgA production by activated ergistically, resulting in induction of differentiation into
B cells either alone (Matsumoto et al., 1989; McIntyre IgM-secreting cells. Moreover, IL-5 can induce differen-
et al., 1995) or in combination with transforming growth tiation of B-1 cells from wild-type mice, but not from
factor b (Coffman et al., 1989; Sonoda et al., 1989). Xid mice. Taking all of these results together, we specu-
In vivo, administration of IL-5 into mice or constitutive late that IL-5 may couple directly or indirectly to the
production of IL-5 in IL-5-Tg mice has been shown to developmental pathway of B-1 cells in which Btk activa-
enhance IgA production (Tominaga et al., 1991). To our tion is indispensable. A partial decrease of B-1 cells in
surprise, the IL-5Ra2/2 mice show normal levels of se- IL-5R2/2 mice may suggest that the targeting disruption
rum IgA (Figure 3A). This discrepancy may be accounted of the IL-5Ra is not enough to abolish the development
for by compensation of cytokines other than IL-5 in IgA of B-1 cells, because Btk activation can be induced
production, or the healthy IL-5Ra2/2 mice may not truly by signals not only through the IL-5 receptor, but also
reflect the ability to mount IgA responses following mu- through the B cell receptor and its coreceptor. As IL-5
cosal challenge. Further studies need to be performed enhances differentiation of mature B-1 cells rather than
to evaluate the role of IL-5 in IgA responses in vivo. their proliferation (Hitoshi et al., 1990), IL-5 may be in-
volved in the expansion of progenitor cells already com-
B-1 Cell Development and IL-5 mitted to differentiate into the B-1-cell lineage and might
Xid mice are known to lack B-1 cells in the peritoneal
not promote the self-renewal activity of mature B-1 cells
cavity and have defects manifested in reduced numbers
in which Btk activation may be required and essential.
of IL-5Ra-expressing B cells, serum IgM and IgG3 defi-
Abnormal B-1 cell development has also been notedciency, high surface IgM to IgD ratios, and a failure to
in mice deficient in the CD19 and Vav molecules thatrespond to anti-IgM stimulation, CD38 ligation, and IL-5
are involved in signaling by the antigen receptor on B(Hitoshi et al., 1993; Kikuchi et al., 1995; Koike et al.,
or T cells (Engel et al., 1995; Rickert et al., 1995; Tarak-1995; Mond, 1982). B-1 cells were decreased signifi-
hovsky et al., 1995; Zhang et al., 1995). CD19 is a Bcantly in the peritoneal cavity of 6- to 8-week-old IL-
cell±specific coreceptor molecule that plays a role in5Ra2/2 mice (Figure 2). The decrease in B-1 cells be-
modifying B cell receptor signaling and is speculatedcame less clear by 13 weeks of age (data not shown).
to regulate efficient selection of B-1 cells by internalThe IL-5Ra2/2 mice have more B-1 cells than Xid mice.
antigen (Rickert et al., 1995). Vav is thought to be down-Serum levels of IgM and IgG3 in the IL-5Ra2/2 mice are
stream of the CD19 signal. The common defect in Blower than those of wild-type mice, but higher than those
cell receptor signaling and reduction of B-1 cells mayof Xid mice. It has been reported that the Btk gene was
suggest an important role of signaling through the B cellmapped to the xid region of the mouse X chromosome
receptor or a closely linked pathway in the generationand Xid mice carry a point mutation that replaces argi-
of B-1 cells. It remains unclear whether IL-5R-mediatednine at position 28 with cysteine. Btk-deficient mice
signaling may couple to signaling pathways through thehave a murine Xid-like phenotype that manifests itself
B cell receptor.in reduced numbers of mature conventional B cells, se-
vere B-1 cell deficiency, serum IgM and IgG3 deficiency,
IL-5 in Eosinophil Productionand defective responses in vitro to various B cell activa-
IL-5 is recognized as an eosinophil differentiation factortors and in vivo to immunization with TI-2antigens (Khan
both in mouse and man (Sanderson, 1992; Takatsu etet al., 1995; Kerner et al., 1995). These results imply that
al., 1994). IL-3 and GM-CSF are also thought to play anBtk signaling is indispensable for the development of
important role in the constitutive production of eosino-B-1 cells and for the functions of conventional B cells.
We do not know what molecular mechanisms underlie phils in bone marrow. It is not clear to what extent IL-5
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plays a role in the constitutive production of eosinophils consistent with in vitro studies demonstrating enhanced
destruction of parasites by IL-5-activated eosinophils.in normal mice. As shown in Table 1, a significantly lower
number of eosinophils is found in the peripheral blood The mice infected with A. cantonensis develop marked
peripheral eosinophilia, and CSF and medullary in-of the IL-5Ra2/2 mice than in wild-type mice. This is
slightly different from the reduction of basal numbers creases in eosinophils. Killing of intracranial worms may
be closely associated with the rapid rise of CSF eosino-of eosinophils in bc2/2 mice in which a more severe
reduction of eosinophils in peripheral blood was re- phils (Sugaya and Yoshimura, 1988). In this study, we
extended these experiments using IL-5Ra-deficient andported (Nishinakamura et al., 1995). Our results also
show that a small, but significant, number of eosinophil IL-5-Tg mice. Results clearly showed that the survival
of intracranial worms is suppressed in IL-5Ra-deficientcolonies in response to IL-3 were generated to similar
degrees in wild-type and IL-5R2/2 mice (Figure 5B). Fur- and is enhanced in IL-5-Tg mice. Taken altogether, our
present results indicate that eosinophils can be incrimi-thermore, in bone marrow cultures of the IL-5Ra2/2 mice
in liquid medium together with IL-3 or GM-CSF, signifi- nated as major effector cells capable of killing intracran-
ial worms in A. cantonensis infected mice. We do notcant numbers of eosinophils were detected and total
numbers of eosinophils were similar to those of bone have any evidence for explaining the mechanism by
which IL-5-induced eosinophils are able to kill A. canto-marrow cultures of wild-type mice (data not shown).
These results suggest the existence of eosinophil± nensis worms. The ability of the IL-5Ra mice to recover
from at least some parasitic infections reported in thisprogenitor cells in bone marrow of the IL-5Ra2/2 mice
and that IL-3 and GM-CSF contribute to the basal eosin- study further confounds efforts to determine the neces-
sity of IL-5-mediated increases in eosinophils for immu-ophil production. Successive passive administration of
IL-5 into wild-type mice induced a selective increase of nologic protection against helminths.
peripheral blood eosinophils, while the same treatment
did not cause peripheral eosinophilia in IL-5Ra2/2 mice. Future Prospects
These results indicate that IL-5 is indispensable for in- The IL-5Ra2/2 mice should facilitate studies of the role
ductive eosinophilopoiesis both in vivo and in vitro. of IL-5 in B-1 cell development and function and in pro-
tection against parasite infection. These mice will also
give us useful tools for further delineating a role for IL-5
Role of IL-5-Induced Eosinophils in the Survival in IgA production and mucosal immunity and provide
of A. cantonensis Intracranial Worms good models for analyzing relationships between IL-5-
Helminthic infections are typically accompanied by an induced eosinophils and airway hyperreactivity. The role
elevation of serum IgE and eosinophilia. Patients with of IL-5 and its receptor system in thymocyte develop-
strongyloidiasis, filariasis, onchochereciasis, or loiasis ment and function is still controversial, although our
have increased numbers of CD41 Th2 cells that produce results suggest an important role for IL-5 in the early
high levels of IL-5 (Greene et al., 1981; Mahanty et al., development of thymocytes. This issue certainly re-
1992; Sher et al., 1990). However, the role of the eosino- quires further studies, and the IL-5Ra2/2 mice will pro-
phil in these infections remained enigmatic until eosino- vide a useful tool for delineating the role of IL-5 signaling
phils were shown to kill schistosomula of Schistosoma in thymocyte development and function. To elucidate
mansoni in vitro in an antibody-dependent reaction. In the function of various domains of the IL-5Ra chain
all cases, however, a relationship between IL-5 and pro- in vivo, complementation studies with mutated IL-5Ra
tection has not been demonstrated. The association be- transgenes can be carried out.
tween eosinophilia and resistance to schistosomiasis
supports the argument that IL-5 plays an important role
Experimental Procedures
in protective immunity against parasitic infections (Ha-
gan et al., 1985). Reagents
The following MAbs were used: H7 MAb (Yamaguchi et al., 1990),There is a body of evidence that the administration
which recognizes mIL-5Ra; RA3±6B2 MAb, which recognizes B220of anti-IL-5 MAb to parasite-infected mice totally and
(American Type Culture Collection [ATCC], Rockville, Maryland); 53-selectively blocked both tissue eosinophil infiltration
7.3 MAb (Ledbetter and Herzenberg, 1979), which recognizes Ly-1and eosinophilia at the premyelocyte stage without al-
(ATCC); GK1.5 MAb, which recognizes CD4 (ATCC); 53-6.72 MAb,
tering IgE levels. Depletion of eosinophils by anti-IL-5 which recognizes CD8 (ATCC); J11D MAb (Bruce et al., 1981), which
MAb did not alter parasite burden or immunologic resis- recognizes heat-stable protein (HSA); H57-597 MAb (Kubo et al.,
1989), which recognizes mouse TCRab; TB13 MAb (Harada et al.,tance to reinfection and granuloma formation, hepatic
1987), which recognizes mIL-5; 2.4G2 MAb, which recognizes mu-fibrosis, or numbers of eggs in the tissues in mice in-
rine FcgR (ATCC); CS/2 MAb (Yamashita et al., 1995), which recog-fected with Trichinella spiralis and Shistosoma mansoni,
nizes mouse CD38; and M1/70 (Springer et al., 1979), which recog-respectively (Herndon and Keys, 1992; Rennick et al.,
nizes mouse Mac-1. Phycoerythrin (PE)-labeled streptavidin (PE±av)
1990; Sher et al., 1990; Goyal and Wakelin, 1993), sug- was purchased from Becton-Dickinson (Mountain View, California).
gesting that eosinophils are nonessential cells in limiting Unlabeled and labeled goat antibodies (anti-mouse IgG1, anti-
mouse IgG2a, anti-mouse IgG2b, and anti-mouse IgG3) were pur-infectious helminths.
chased from Southern Biotechnology Associates (Birmingham, Ala-A similar depletion of eosinophils by anti-IL-5 MAb
bama). Unlabeled and horseradish peroxidase (HRP)-labeled goatwas demonstrated in mice infected with many other
anti-mouse IgM antibodies and HRP-labeled streptavidin (HRP±av)parasites (Herndon and Kayes, 1992; Korenaga et al.,
were purchased from Zymed Laboratories (San Francisco, Califor-
1994; Yoshimura et al., 1994). Ablation of eosinophils nia). Normal rat IgG and normal hamster IgG were purified from
with anti-IL-5 MAb decreases the survival of mice in- sera with caprylic acid (Sigma, St. Louis, Missouri) as previously
described (Koike et al., 1995).fected with A. cantonensis (Sasaki et al., 1993), which is
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LPS was obtained from Difco Laboratories (Detroit, Michigan). T cells, utilizing anti-Thy1.2 MAb (Serotech, Blackthorn, Bicester,
United Kingdom) and guinea pig complement. Whole spleen cellsRecombinant mIL-4 and mGM-CSF were provided by Ono Pharma-
ceutical, Incorporated (Minase, Japan) and Kirin Brewery Company, or T cell±depleted splenocytes showed no proliferative response to
ConA. These cells were cultured in 96-well flat-bottomed microtiterLimited (Maebashi, Japan), respectively. Recombinant mouse IL-5
was purified as previously described (Takaki et al., 1990). Mouse plates in RPMI 1640 medium supplemented with 8% fetal calf serum,
L-glutamine (2 mM), 2-mercaptoethanol (2-ME) (50 mM), penicillinIL-3 was purchased from GIBCO Company, Limited.
(50 mg/ml), and streptomycin (50 mg/ml), with or without various
cytokines. Proliferation assays of B cells stimulated with LPS, CS/Strategy for the Disruption of the IL-5Ra Chain Gene
A 129/Sv genomic library in lFIXII (Stratagene) was screened using 2, and anti-IgM plus IL-4 were carried out in triplicate as previously
described (Kikuchi et al., 1995; Hayashi et al., 1986). The uptake ofprobes from the mIL-5Ra cDNA (Takaki et al., 1990; Imamura et al.,
1994), and partially overlapping 15 kb and 14.5 kb fragments that [3H]thymidine was measured as described (Uehara et al., 1994).
Numbers of anti-TNP IgM±PFC were determined as previously de-encompassed from exon 1±8 were isolated. The vector used for
the disruption of the IL-5Ra gene contained a genomic fragment scribed (Hayashi et al., 1986).
spanning exons 3 and 7. BglII fragments (1.3 kb) containing exons
5 and 6 were once subcloned into pBluescript KS(1), and a transla- ELISA Assays
tional stop codon with a HindIII site (TAAGCTT) was introduced in Each immunoglobulin isotype in sera was quantitated by ELISA with
frame into by using ploymerase chain reaction into the upstream of antibodies specific for each mIg isotype according to procedures
the codon for the first cysteine residue inexon 5 among four cysteine previously described (Uehara et al., 1994). Flexible 96-well trays
residues in the conserved motif of the cytokine receptor superfamily. (Becton-Dickinson) were coated with 5 mg/ml of isotype-specific
Then 1.8 kb of a neomycin resistance gene (pgk±neo poly[A]1) was goat anti-mouse antibodies. Diluted serum samples were incubated
inserted into the SphI site of exon 6, which contains the third and in the plates and biotinylated isotype-specific goat anti-mouse im-
fourth cysteine residues of the cytokine receptor motif, and inacti- munoglobulin antibodies were added to each well and the plates
vated four cysteine residues of the exon. A 5.0 kb 59 homologous were incubated for another 2 hr at room temperature. After washing
region containing exons 3 and 4, and a 3.7 kb 39 homologous region with phosphate-buffered saline containing Triton X-100, HRP±
containing exon 7 were added, respectively. An MC1±tk cassette streptavidin was added to each well and incubated for 1 hr at room
was ligated to the 59 end of the homologous region, then linear- temperature. Finally, plates were washed with the buffer and 100
ized by digesting with NotI at multiple cloning sites of the pBlue- ml aliquots of substrate, O-phenylenediamine (final, 0.4 mg/ml), and
script KS(1). hydrogen peroxide (final, 0.015%) were added to each well. The
The linearized vector was introduced by electroporation into E14.1 enzyme reaction was stopped by adding 2 M sulfuric acid and
ES cells and resistant colonies were selected with G418 (225 mg optical density at 495 nm was measured with a Vmax kinetic Micro
active weight/ml) and FIAU (0.2 mM). The ES clones carrying the IL- Plate Reader (Molecular Devices, Palo Alto, California). Using my-
5Ra targetedmutation onone allele through a homologous recombi- eloma proteins (Miles Scientific, Naperville, Illinois), standard curves
nation event were screened by Southern blot analysis after SacI were generated for each isotype and concentrations of mIg were
digestion using a 0.5 kb HindIII±XbaI fragment containing exon 2 determined with a Delta-Soft computer program (Biometallics,
as a probe (probe A), which identified a 10.7 kb mutant band in Princeton, New Jersey).
addition to a 13 kb wild-type band. Results were also verified by
hybridization of PstI digests with a 39 flanking 0.9 kb HindIII fragment Clonal Cell Culture
of intron 8 as a probe (probe B), resulting in a 13 kb mutant band Methylcellulose culture was carried out in 35 mm suspension culture
in addition to a 17 kb wild-type band. A HindIII digest hybridized dishes (model 171099, Nunc, Incorporated) as previously described
with probe A yielded a 6.0 kb band for the mutated allele and 8.2 (Sonoda et al., 1989). In brief, bone marrow cells (2 3 104/ml) from
kb for the wild type, which was due to the artificially introduced
wild-type or IL-5R2/2 mice were cultured at 378C in a humidified
HindIII site with the stop codon in exon 5. Hybridization with a neor
atmosphere with 5% CO2 in air in medium consisting of a-mediumgene probe was performed to ensure a single integration site (data
containing 0.9% 4000 centipoises methylcellulose (Fisher, Norcross,
not shown).
California), 30% fetal calf serum (Hyclone Laboratories, Logan,Mutant clones were injected into blastocysts of C57BL/6 mice
Utah), 1% deionized fraction V bovine serum albumin (Sigma), 100and the resulting male chimeras were mated to C57BL/6 females
mM 2-ME, and hematopoietic growth factors; murine IL-3 (10 ng/to test for germline transmission of the mutation. Offspring derived
ml), murine GM-CSF (10 ng/ml), and various concentrations of mu-from ES cells were identified by coat color and screened for the
rine IL-5. Colony types were determined periodically during incuba-presence of the targeted allele by Southern blot analysis of PstI-
tion by in situ observation with an inverted microscope accordingdigested tail DNA with probe B. Heterologous offspring showed the
to the criteria described previously (Takagi et al., 1995). Ex-13 kb fragment of the mutant allele in addition to the 17 kb wild-type
cept for megakaryocyte colonies, colonies consisting of >50 cellsallele. By interbreeding the heterozygous offspring, we obtained
were scored. Abbreviation of colony types are as follows: GM, gran-homozygous mutantanimals that were,due to the breeding strategy,
ulocyte±macrophage colonies; GMM, granulocyte±macrophage±on the (129/Ola 3 C57BL/6)F2 hybrid background. We maintained
megakaryocyte colonies; G, granulocyte colonies; MEG, mega-mice under specific pathogen-free conditions and used them at
karyocyte colonies; Mast, mast cell colonies; and Eo, eosinophilabout 6±13 weeks of age for experiments.
colonies.
Flow Cytometry
Parasite and InfectionFor immunofluorescence studies, MAbs were coupled to biotin
The third-stage infective larvae (L3) of A. cantonensis were har-(Pierce, Rockford, Illinois) or fluorescein isothiocyanate (FITC)
vested as described (Yoshimura and Soulsby, 1976). Either C3H/(Sigma) according to procedures previously described (Hitoshi et
HeN mice (Clea Company, Limited, Japan), IL-5-Tg mice (Tominagaal., 1990). Cells (1±10 3 105) from thymocytes, bone marrow, spleen,
et al., 1991), or IL-5Ra2/2 mice and their littermates were orallylymph nodes, and the peritoneal cavity were stained with biotinyl-
infected with 22±30 L3. Nucleated cells and eosinophils in CSF wereated MAb or FITC-labeled MAb for 30 min at 48C, with 2.4G2 MAb
enumerated as described elsewhere (Sugaya and Yoshimura, 1988).(10 mg/ml) to avoid nonspecific binding of the labeled MAbs. After
Brains were removed, crushed, and examined for viable wormswashing, cells were incubated with 50 ml PE±av for 20 min at 48C.
under a dissecting microscope 20 days after the infection. WormsAfter washing, cells were suspended in a buffer containing 1%
harvested were fixed in 10% neurtal formalin and measured as de-7-amino-actinomycin D (Sigma) to exclude dead cells from the analy-
scribed elsewhere (Yoshimura et al., 1979).sis. Fluorescence intensity was measured with a FACScan instru-
ment (Becton-Dickinson).
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